Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-017781

Chief Financial Officer bought 15,000 shares at $0.37 ($5,550)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-10 Purchase : show line 1 in the form +15,000 $0.37 $5,550 167,272 D
Open-market purchases · 15,000 sh · avg $0.37 · $5,550
Loading xslF345X03/doc4.xml…